Morning Briefing
Summaries of health policy coverage from major news organizations
GSK To Donate 50M H1N1 Vaccine Doses To WHO In Coming Months
Drugmaker GlaxoSmithKline announced plans on Tuesday to donate 50 million doses of its H1N1 (swine flu) vaccine to the WHO for use in developing countries within the next few months, Reuters reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.